KnowHow: The FDB Blog

Pharmacists Comparing Labels

Reducing Errors from Look-Alike, Sound-Alike Medication Names: The Role of Indications

Corporate Perspective, Information Systems
Thursday, October 4, 2018 by Christine Cheng, PharmD

Medication names that look or sound similar are problematic because they can be easily confused with each other. Examples of look-alike, sound-alike (LASA) medication names include hydralazine-hydroxyzine, Keflex-Keppra, metronidazole-metformin, Zyprexa-Zyrtec and Actonel-Actos. At least one out of every 1,000 prescriptions in the United States is associated with a wrong-medication error, and name confusion is thought to be a key cause. Read more...

Comments (0)
Footsteps Following

Footstep Following: A Sure-Fire Route to Medical Device Compendia Success

Corporate Perspective, Transformational Change
Thursday, August 9, 2018 by Julie Suko, PharmD

The problem: medical device information within information systems currently is unstructured, incomplete, and in many cases simply unavailable. Fortunately, we are on the precipice of eliminating these unfortunate if onlys. Read more...

Comments (0)
Seniors and Pill Bottles

Getting Medications Out of the Bottle: The Importance of Patient Engagement

Corporate Perspective, Transformational Change, Information Systems
Monday, June 25, 2018 by Charles Lee, MD

Patient engagement is defined by the Center for Advancing Health as “actions individuals must take to obtain the greatest benefit from the health care services available to them.” Certainly, such engagement is essential when it comes to one of the most important patient actions of all: taking medications. After all, as a Yoruba proverb says: “Medicine left in the bottle can’t help.” Read more...

Comments (0)
Puzzle Pieces

An Interview with Jay Crowley: An Insider’s Look at Unique Device Identifiers, Part 2

FDA, Transformational Change
Monday, May 14, 2018 by Jay Crowley

FDB recently interviewed Jay Crowley to get his expert perspective on the Unique Device Identification (UDI) system. This is the second of a two-part blog series where Crowley offers his thoughts on the evolution and future of this emerging identification system. Read more...

Comments (0)
Puzzle Pieces

An Interview with Jay Crowley: An Insider's Look at Unique Device Identifiers

FDA, Transformational Change
Monday, April 16, 2018 by Jay Crowley

FDB recently interviewed Jay Crowley to get his expert perspective on the Unique Device Identification (UDI) system. This is the first of a two-part blog series where Crowley offers his thoughts on the evolution and future of this emerging identification system. Read more...

Comments (1)
View more

Don't Miss a Single Post!

Be notified about new FDB Blog posts as they are published by submitting the information below. (If you are already an FDB Customer in North America, you are automatically receiving blog updates by email and do not need to sign up.)

*
*
*

Blogger Spotlight

Christine Cheng

Christine Cheng, PharmD
Clinical Pharmacist

Julie Suko, PharmD

Julie Suko, PharmD
Director, Editorial Services

Charles Lee, MD

Charles Lee, MD
Senior Director, Meducation

Jay Crowley

Jay Crowley
VP, USDM Life Sciences

Lee Ann McWhorter

Lee Ann McWhorter
Strategic Alliances Director

Josh Young
Director, Software Development

Tom Bizzaro

Tom Bizzaro, RPh
VP, Health Policy

Helena Dummler

Helena Dummler, PharmD
Clinical Pharmacist

Ray Pedden

Ray Pedden
Strategy and Innovation, CCI

Nick Ratto

Nick Ratto, PharmD
Manager, Consumer Drug Info

Pat Lupinetti

Patrick Lupinetti, JD
Senior VP and Editorial Director

Brad Engels

Brad Engels
Associate Product Manager

Dewey Howell

Dewey Howell, MD, PhD
VP, Clinical Applications

Doris Yee, PharmD

Doris Yee, PharmD
Clinical Pharmacist